Advanced search
Publication Cover
Clinical Ophthalmology Volume 14, 2020 - Issue
Submit an article Journal homepage
157
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Difluprednate 0.05% versus Prednisolone Acetate Post-Phacoemulsification for Inflammation and Pain: An Efficacy and Safety Clinical Trial

Claudia Palacio-Pastrana1 Fundación Hospital Nuestra Señora de la Luz, IAP, CDMX, MexicoORCID Iconhttps://orcid.org/0000-0002-3366-5645
ORCID Icon,
Eduardo Chávez-Mondragón2 Fundación de Asistencia Privada Conde de Valenciana, IAP, CDMX, MexicoORCID Iconhttps://orcid.org/0000-0002-3665-0254
ORCID Icon,
Abraham Soto-Gómez3 Catarata y Glaucoma de Occidente SA de CV, Guadalajara, Jalisco, MexicoORCID Iconhttps://orcid.org/0000-0003-3588-1322
ORCID Icon,
Rubén Suárez-Velasco4 Private Office, Guadalajara, Jalisco, Mexico
,
Miguel Montes-Salcedo5 Aris Vision Institute, Guadalajara, Jalisco, Mexico
,
Lourdes Fernández de Ortega6 Asociación Para Evitar la Ceguera en México, IAP, CDMX, Mexico
,
Linda Nasser-Nasser7 Visión Cirugía Ambulatoria, Monterrey, Nuevo Leon, MexicoORCID Iconhttps://orcid.org/0000-0001-7216-1522
ORCID Icon,
Leopoldo Baiza-Durán8 Medical Affairs, Laboratorios Sophia, SA de CV, Zapopan, Jalisco, Mexico
,
Oscar Olvera-Montaño8 Medical Affairs, Laboratorios Sophia, SA de CV, Zapopan, Jalisco, MexicoORCID Iconhttps://orcid.org/0000-0003-2717-349X
ORCID Icon &
Patricia Muñoz-Villegas8 Medical Affairs, Laboratorios Sophia, SA de CV, Zapopan, Jalisco, MexicoCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7559-1218
ORCID Icon show all
Pages 1581-1589 | Published online: 12 Jun 2020

References

  • Batlle JF, Lansingh VC, Reskinoff S, et al. The cataract simulation in Latin America: barriers to cataract surgery. Am J Ophthalmol. 2014;158(2):242–250.e1. doi:10.1016/j.ajo.2014.04.019
  • Chaudhary N, Arora I, Gupta DC, Gupta CP. Comparison of efficacy and safety of dexamethasone 0.1% and difluprednate 0.05% in the management of ocular inflammation after phacoemulsification. J Evol Med Dent Sci. 2015;4(74):12899–12903. doi:10.14260/jemds/2015/1860
  • Apple DJ, Solomon KD, Kostick AM, et al. Posterior capsule opacification. Surv Ophthalmol. 1992;37(2):73–116. doi:10.1016/0039-6257(92)90073-3
  • Tijunelis MA, Person E, Shahzad IM, et al. Comparison of prednisolone acetate 1.0% and difluprednate ophthalmic emulsion 0.05% after cataract surgery: incidence of postoperative steroid-induced ocular hypertension. J Cataract Refract Surg. 2017;43(2):223–227. doi:10.1016/j.jcrs.2017.02.002
  • El-Harazi SM, Feldman RM. Control of intra-ocular inflammation associated with cataract surgery. Curr Opin Ophthalmol. 2001;12(1):4–8. doi:10.1097/00055735-200102000-00002
  • Garg P, Tuteja N, Qayum S. To study the efficacy of difluprednate ophthalmic emulsion and prednisolone acetate ophthalmic suspension on post-operative inflammation in cataract surgery. J Clin Diagn Res. 2016;10(12):NC05–NC08. doi:10.7860/JCDR/2016/21690.9035
  • Donnenfeld ED. Difluprednate for the prevention of ocular inflammation postsurgery: an update. Clin Ophthalmol. 2011;5:811–816. doi:10.2147/OPTH.S6541
  • Rajpal RK, Fong R, Comstock TL. Loteprednol etabonate ophthalmic gel 0.05% following cataract surgery: integrated analysis of two clinical studies. Adv Ther. 2013;30(10):907–923. doi:10.1007/s12325-013-0059-7
  • Wilson ME, O’Halloran H, Lambert SR, et al. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. Eye (Lond). 2016;30(9):1187–1194. doi:10.1038/eye.2016.132
  • Demco TA, Sutton H, Demco CJ, Raj PS. Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification-lens implant surgery. Eur J Ophthalmol. 1997;7(3):236–240. doi:10.1177/112067219700700306
  • Donnenfeld ED, Holland EJ, Perry HD, et al. A multicenter randomized controlled fellow eye trial of pulse-dose difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery. Am J Ophthalmol. 2011;152(4):609–617.e1. doi:10.1016/j.ajo.2011.03.018
  • Kakimoto H, Takamura Y, Inatani M, et al. Effect of 0.05% difluprednate ophthalmic emulsion on proinflammatory cytokine levels after retinal laser photocoagulation in rabbits. J Ocul Pharmacol Ther. 2018;34(5):410–415. doi:10.1089/jop.2017.0109
  • Abessi B, Brooksby L, Schultze RL. Comparison of efficacy of difluprednate 0.05% and loteprednol gel 0.5% after cataract surgery. Eye Contact Lens. 2018;44(2):S37–S42. doi:10.1097/ICL.0000000000000407
  • Mercado-Sesma A, Contreras-Rubio A, Bonilla-García J, et al. Bioavailability of generic 0.05% difluprednate emulsion in the aqueous humor, cornea, and conjunctiva of New Zealand rabbits after a single dose compared with commercial difluprednate. J Ophthalmic Inflamm Infect. 2017;7(1):10. doi:10.1186/s12348-017-0127-2
  • Lyseng-Williamson KA. Loteprednol etabonate ophthalmic gel 0.5%: a review of its use in post-operative inflammation and pain following ocular surgery. Drugs. 2013;73(9):948–958. doi:10.1007/s40265-013-0073-8
  • Foster CS, Vitale AT, editors. Diagnosis and Treatment of Uveitis. Philadelphia: WB Saunders Company; 2002.
  • Chow S-C, Shao J, Wang H. Sample Size Calculations in Clinical Research (2nd Ed). Boca Raton, FL: Chapman and Hall/CRC; 2008.
  • Linebarger EJ, Hardten DR, Shah G, Lindstrom RL. Phacoemulsification and modern cataract surgery. Surv Ophthalmol. 1999;44(2):123–147. doi:10.1016/S0039-6257(99)00085-5
  • Coassin M, De Maria M, Fontana L, et al. Anterior chamber inflammation after cataract surgery: a randomized clinical trial comparing bromfenac 0.09% to dexamethasone 0.1. Adv Ther. 2019;36(10):2712–2722. doi:10.1007/s12325-019-01076-4
  • Korenfeld MS, Silverstein SM. Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. J Cataract Refract Surg. 2009;35(1):26–34. doi:10.1016/j.jcrs.2008.09.024
  • Novack GD, Robin AL. Ocular pharmacology. J Clin Pharmacol. 2016;56(5):517–527. doi:10.1002/jcph.634
  • Gomez Bastar PA, Lansingh VC, López Star EM, et al. Cataract remains the primary cause of blindness in emerging economies, including Mexico. Rev Mex Oftalmol. 2014;88(4):208–209.
  • kaur S, Sukhija J. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. Eye (Lond). 2017;31(3):506. doi:10.1038/eye.2016.243

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.